Chemoinformaics analysis of 1,54-Dibromotetrapentacontane
| Molecular Weight | 917.266 | nRot | 53 |
| Heavy Atom Molecular Weight | 808.402 | nRig | 2 |
| Exact Molecular Weight | 914.682 | nRing | 0 |
| Solubility: LogS | 0.24 | nHRing | 0 |
| Solubility: LogP | -0.735 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 164 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 108 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 54 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 168.294 |
| nHD | 0 | BPOL | 111.106 |
| QED | 0.38 |
| Synth | 1.687 |
| Natural Product Likeliness | 0.422 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.21 |
| CACO-2 | -5.896 |
| MDCK | 0.00168336 |
| BBB | 0.179 |
| PPB | 0.153026 |
| VDSS | 0.292 |
| FU | 0.674685 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.05 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.209 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.013 |
| CL | 1.754 |
| T12 | 0.893 |
| hERG | 0.024 |
| Ames | 0.026 |
| ROA | 0.038 |
| SkinSen | 0.504 |
| Carcinogencity | 0.014 |
| EI | 0.994 |
| Respiratory | 0.068 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.609924 |